These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 27881260)
1. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore. Wang P; Luo N; Tai ES; Thumboo J Value Health Reg Issues; 2016 May; 9():57-62. PubMed ID: 27881260 [TBL] [Abstract][Full Text] [Related]
2. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029 [TBL] [Abstract][Full Text] [Related]
3. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients. Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574 [TBL] [Abstract][Full Text] [Related]
5. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637 [TBL] [Abstract][Full Text] [Related]
6. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Pattanaphesaj J; Thavorncharoensap M Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017 [TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Loucks L; Al Khudairy A; Noseworthy TW Qual Life Res; 2015 Jul; 24(7):1775-84. PubMed ID: 25555837 [TBL] [Abstract][Full Text] [Related]
8. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Feng Y; Devlin N; Herdman M Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956 [TBL] [Abstract][Full Text] [Related]
9. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
10. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran. Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594 [TBL] [Abstract][Full Text] [Related]
11. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430 [TBL] [Abstract][Full Text] [Related]
12. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418 [TBL] [Abstract][Full Text] [Related]
13. Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study. Perez-Sousa MA; Olivares PR; Gusi N Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141694 [TBL] [Abstract][Full Text] [Related]
14. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788 [TBL] [Abstract][Full Text] [Related]
15. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing. Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993 [TBL] [Abstract][Full Text] [Related]
16. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia. Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138 [TBL] [Abstract][Full Text] [Related]
17. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Koszorú K; Hajdu K; Brodszky V; Bató A; Gergely LH; Kovács A; Beretzky Z; Sárdy M; Szegedi A; Rencz F Eur J Health Econ; 2023 Feb; 24(1):139-152. PubMed ID: 35412162 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Yfantopoulos J; Chantzaras A; Kontodimas S Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371 [TBL] [Abstract][Full Text] [Related]
19. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China. Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889 [TBL] [Abstract][Full Text] [Related]
20. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. Michalowsky B; Hoffmann W; Xie F J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]